
SentiSense
Ctrl+K
Quick tip: Press
to search stocks
I
IDXX
IDEXX Laboratories, Inc.
$573.82
+2.61 (+0.46%)
Summary
Stories
News
Metrics
Fundamentals
Holders
Full institutional holders data is a Pro feature
UpgradeInstitutional Holders
1269
tracked filers
Total Institutional Value
$27.8B
1269 holders tracked
Report Date
Q4 2025
SEC 13F-HR filing
| Holder | Category | Shares | Value | Weight | Change |
|---|---|---|---|---|---|
VANGUARD GROUP INC | Index Fund | 9.2M | $5.9B | -- | -3.1% |
STATE STREET CORP | Index Fund | 3.5M | $2.2B | -- | -1.0% |
Fundsmith LLP | Other | 2.6M | $1.7B | -- | -1.1% |
GEODE CAPITAL MANAGEMENT, LLC | Index Fund | 2.3M | $1.5B | -- | +1.2% |
BAMCO INC /NY/ | Other | 1.9M | $1.2B | -- | -7.3% |
Data source: SEC EDGAR 13F-HR filings
Company Profile
Symbol
IDXX
Market Cap
$45.48B
IPO Date
Jun 21, 1991
CEO
--
Employees
11,000
Sector
--
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Country
United States
Exchange
--
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Read MoreSimilar Stocks
A
Agilent Technologies, Inc.
$111.51
-0.11%
TMO
Thermo Fisher Scientific Inc.
$464.37
-2.42%
HOLX
Hologic, Inc.
$75.12
-0.12%